Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing

NCT01969370 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT01969370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01969370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2012
Completion date
March 1, 2017
Enrollment
645 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, cardiovascular disease, congenital abnormalities, hearing loss, neurologic dysfunction